No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Information Technology Services
Arribatec Solutions ASA, established in 2015 and headquartered in Oslo, Norway, is a global software and consulting firm providing an extensive array of digital business solutions. Their comprehensive offerings cater to diverse corporate needs, including enterprise resource planning (ERP), cloud and IT infrastructure, business intelligence (BI), enterprise architecture (EA) and business process management (BPM), custom software development, and specialized applications for the hospitality and marine sectors. Key solutions provided by the company include QualiWare, an enterprise architecture and business management tool designed to drive digital transformation; Unit4, a cloud-native, intelligent ERP system; InfoSHIP, a specialized web-based software for managing various marine vessels such as cruise ships, tankers, cargo, bulk, and ferries; Boson Go, an application extending QualiWare's capabilities; OLKWEB, for apprenticeship tracking, training, and administration; Instipro3, for streamlined research project management; RamBase, an ERP platform that enhances supply chain control; Power BI, a potent analytics tool for generating insights from diverse data through interactive reports and dashboards; Hypergene, a performance optimization solution; innovative holographic and self-service kiosks; the Certify Housekeeping tool for efficient daily departmental operations; a dedicated GDPR Portal; and robust Microsoft Azure cloud environment solutions.
www.arribatec.comNo one on the platform currently holds ARR.OL.
No tracked institution reports a position in ARR.OL as of their last filing.
No one on the platform has traded ARR.OL yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.5% | — | — | — | ||
| Rev. Growth % | 0.7% | 30.3% | ||||
| Profit Margin % | 9.4% | -7.5% | -182.0% | |||
| Free Cash Flow Margin % | 1.3% | -3.4% | -122.8% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $586M | -0.3% | $0.54 | $0.54–$0.54 | — | 1 |
| 2027 | $635M | +8.2% | $0.82 | $0.82–$0.82 | — | 1 |
| 2028 | $678M | +6.9% | $0.88 | $0.88–$0.88 | — | 1 |
| 2029 | $735M | +8.4% | $0.00 | $0.00–$0.00 | — | 0 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 2 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-27 | $0.13 | $0.08 | -33.6% |
| 2026-05-20 | $0.09 | $0.10 | +17.7% |
| 2025-10-30 | $0.18 | $0.17 | -4.8% |
| 2025-08-21 | $0.18 | $0.14 | -21.6% |
| 2025-05-28 | $-0.25 | $1.10 | +531.5% |
| 2025-02-28 | $0.18 | $-6.90 | -3965.5% |
| 2024-11-06 | $0.07 | $-0.21 | -400.0% |
| $154M |
| — |
| IDEX.OLIDEX Biometrics ASA | $6.00 | +0.00% | $464M | — |
| ITERA.OLItera ASA | $5.84 | -2.67% | $474M | — |
Source: Financial Modeling Prep · peers by sector/industry